Omeprazole Unifarma (Omeprazole Sodium)

Omeprazole Sodium, the active ingredient in Omeprazole Unifarma, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazole Unifarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole Unifarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Unifarma is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence or bloating. - Constipation.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Fracture risk: possible reduction in bone mineral density with long‑term use. - Severe allergic reactions: anaphylaxis or angio‑edema.

Before using Omeprazole Unifarma, consider the following safety measures: - Assess patient history: evaluate for prior hypersensitivity to PPIs. - Monitor long‑term use: periodic assessment of magnesium, calcium, and vitamin B12 levels is advised. - Evaluate renal function: adjust use in patients with severe renal impairment. - Use in pregnancy: discuss risks and benefits with a healthcare professional. - Use in breastfeeding: weigh potential infant exposure against maternal benefit. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Omeprazole can interact with several medicines, affecting their absorption or metabolism.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased antiviral efficacy due to reduced gastric acidity. - Dasatinib: lower absorption leading to reduced therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer coagulation monitoring. - Phenytoin: may reduce serum levels, necessitating dosage adjustment. - Methotrexate: increased exposure risk, especially at high doses.